TRDA
Entrada Therapeutics, Inc. · Healthcare
Chief Medical Officer Nerissa Kreher sold $131K of Entrada Therapeutics, Inc.
Sold$131,428
$15.29Price
8,593Shares
−29%Stake
What TRDA did after the filing
- The stock from Wed, Sep 28 close, $15.81
- +20.4%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Nov 9 close.
Traded Mon, Sep 26. Filed Wed, Sep 28, 1:10 PM ET, during the session. Returns use the Sep 28 close and the Nov 9 close. Not investment advice.